Cargando…
Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital
BACKGROUND: International osteoporosis foundation described severe or established osteoporosis as an osteoporotic individual with a fragility fracture. Orthopaedic surgeons frequently manage fractures, but we believe that large gaps are prevalent in the medical management of osteoporosis after fract...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991939/ https://www.ncbi.nlm.nih.gov/pubmed/24761237 http://dx.doi.org/10.4103/2141-9248.129038 |
_version_ | 1782312526977957888 |
---|---|
author | Sadat-Ali, Mir Al-Omran, AS Al-Bakr, WI Azam, Md Quamar Tantawy, AM Al-Othman, AA |
author_facet | Sadat-Ali, Mir Al-Omran, AS Al-Bakr, WI Azam, Md Quamar Tantawy, AM Al-Othman, AA |
author_sort | Sadat-Ali, Mir |
collection | PubMed |
description | BACKGROUND: International osteoporosis foundation described severe or established osteoporosis as an osteoporotic individual with a fragility fracture. Orthopaedic surgeons frequently manage fractures, but we believe that large gaps are prevalent in the medical management of osteoporosis after fractures are fixed. AIM: The aim of this analysis is to assess the investigations and gaps in the management of osteoporosis in patients admitted with a fragility fracture of femur at King Fahd Hospital of the University, AlKhobar, Saudi Arabia. MATERIALS AND METHODS: A retrospective analysis of all admission and discharge; medical and pharmacy records database of patients over ≥ 50 years with fragility fracture between January 2001 and December 2011. The outcome measures assessed were investigations such as serum calcium, phosphorous, alkaline phosphatase, parathormone, 25 hydroxy vitamin D (25OHD) levels and a dual energy X-ray absorptiometry (DEXA). Secondly once the fracture was fixed what medications were prescribed, calcium and vitamin D, antiresorptives and anabolic agents. RESULTS: There were 207 patients admitted during the study period with an average age of 69.2 (12.1) years and 118 were females. In 169 (81.6%) patients, the fracture site was proximal femur. Vitamin D (25OHD) was requested in 31/207 (14.9%). DEXA scan was ordered in 49/207 (24.1%). A total of 78/207 (37.6%) patients received calcium and vitamin D3 and 94/207 (45.4%) either got calcium or vitamin D3. Bisphosphonates was used in 35, miacalcic nasal spray in 25 and anabolic agent teriparatide was prescribed in 21 patients. Post-fixation 126/207 (60.8%) patients did not receive any anti-osteoporotic medication. In untreated group, there were 87 males and 39 females. CONCLUSIONS: The study found that in patients, who sustained a fragility fracture, confirmation of osteoporosis by DEXA was very low and ideal treatment for severe osteoporosis was given out to few patients. More efforts are needed to fill this large gap in the correct management of osteoporosis related fractures by orthopaedic surgeons. |
format | Online Article Text |
id | pubmed-3991939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39919392014-04-23 Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital Sadat-Ali, Mir Al-Omran, AS Al-Bakr, WI Azam, Md Quamar Tantawy, AM Al-Othman, AA Ann Med Health Sci Res Original Article BACKGROUND: International osteoporosis foundation described severe or established osteoporosis as an osteoporotic individual with a fragility fracture. Orthopaedic surgeons frequently manage fractures, but we believe that large gaps are prevalent in the medical management of osteoporosis after fractures are fixed. AIM: The aim of this analysis is to assess the investigations and gaps in the management of osteoporosis in patients admitted with a fragility fracture of femur at King Fahd Hospital of the University, AlKhobar, Saudi Arabia. MATERIALS AND METHODS: A retrospective analysis of all admission and discharge; medical and pharmacy records database of patients over ≥ 50 years with fragility fracture between January 2001 and December 2011. The outcome measures assessed were investigations such as serum calcium, phosphorous, alkaline phosphatase, parathormone, 25 hydroxy vitamin D (25OHD) levels and a dual energy X-ray absorptiometry (DEXA). Secondly once the fracture was fixed what medications were prescribed, calcium and vitamin D, antiresorptives and anabolic agents. RESULTS: There were 207 patients admitted during the study period with an average age of 69.2 (12.1) years and 118 were females. In 169 (81.6%) patients, the fracture site was proximal femur. Vitamin D (25OHD) was requested in 31/207 (14.9%). DEXA scan was ordered in 49/207 (24.1%). A total of 78/207 (37.6%) patients received calcium and vitamin D3 and 94/207 (45.4%) either got calcium or vitamin D3. Bisphosphonates was used in 35, miacalcic nasal spray in 25 and anabolic agent teriparatide was prescribed in 21 patients. Post-fixation 126/207 (60.8%) patients did not receive any anti-osteoporotic medication. In untreated group, there were 87 males and 39 females. CONCLUSIONS: The study found that in patients, who sustained a fragility fracture, confirmation of osteoporosis by DEXA was very low and ideal treatment for severe osteoporosis was given out to few patients. More efforts are needed to fill this large gap in the correct management of osteoporosis related fractures by orthopaedic surgeons. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC3991939/ /pubmed/24761237 http://dx.doi.org/10.4103/2141-9248.129038 Text en Copyright: © Annals of Medical and Health Sciences Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Sadat-Ali, Mir Al-Omran, AS Al-Bakr, WI Azam, Md Quamar Tantawy, AM Al-Othman, AA Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title | Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title_full | Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title_fullStr | Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title_full_unstemmed | Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title_short | Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital |
title_sort | established osteoporosis and gaps in the management: review from a teaching hospital |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991939/ https://www.ncbi.nlm.nih.gov/pubmed/24761237 http://dx.doi.org/10.4103/2141-9248.129038 |
work_keys_str_mv | AT sadatalimir establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital AT alomranas establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital AT albakrwi establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital AT azammdquamar establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital AT tantawyam establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital AT alothmanaa establishedosteoporosisandgapsinthemanagementreviewfromateachinghospital |